-
Jim Cramer Highlights 'Transformational' Impact Of Weight Loss Drugs Like Ozempic: Focus Now On 'Potential Winners' From The Same Narrative
Monday, December 4, 2023 - 9:24pm | 645Read More...What Happened: Jim Cramer outlined fresh investment prospects on Monday, revolving around the growing demand for GLP-1 drugs, typically administered for diabetes and obesity treatment. As reported by CNBC, investors initially expressed concerns about these drugs’ market impact. However, with...
-
Novartis' CEO Says Company Open To Selling Its $14 Billion Stake In Roche 'If The Opportunity Were Right'
Wednesday, May 25, 2016 - 9:41am | 207Read More...Switzerland-based Novartis AG (ADR) (NYSE: NVS) owns a roughly $14 billion stake in rival Roche Holding Ltd. (ADR) (OTC: RHHBY) and is actively shopping for buyers to acquire its stake. According to Reuters, Novartis has been working with bankers to explore the sale of its stake in Roche and would...
-
Jefferies Names AbbVie As Top Pharmaceutical Pick, Offers Alternative Choices
Friday, February 20, 2015 - 2:10pm | 329Read More...In a report published Friday, Jefferies analyst Jeffrey Holford named AbbVie Inc (NASDAQ: ABBV) as a "Top Global Pick" in the Pharmaceutical space, replacing Pfizer Inc. (NYSE: PFE). Holford added that shares have seen significant pressure since mid-December as the initial...
